influenza virus infections in the general population flu influenza
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: participants with known allergic status
Exclusion criteria
Exclusion criteria: immunological disorders active viral or bacterial infections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proposed experiments will allow us to quantify the predictability of influenza virus evolution and under what circumstances that evolution is predictable. If predictable, the protocols from this study will be used to inform the World Health Organization Influenza Vaccine Strain Selection process (the project leader was a member of the WHO committee that oversees this process from 2009-2015). If evolution is not meaningfully predictable the project results will be used to inform other vaccine design efforts. | — |
Secondary
| Measure | Time frame |
|---|---|
| does not apply | — |
Countries
Netherlands
Outcome results
None listed